![Drew Deniger](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profiel
Drew Deniger formerly worked at Alaunos Therapeutics, Inc., as Vice President-Research & Development from 2022 to 2023.
Dr. Deniger received his doctorate degree in 2013 from Anderson University and undergraduate degree in 2002 from The University of Texas at Austin.
Eerdere bekende functies van Drew Deniger
| Bedrijven | Functie | Einde |
|---|---|---|
| ALAUNOS THERAPEUTICS, INC. | Hoofd Techniek/Wetenschap/O&O | 15-11-2023 |
Opleiding van Drew Deniger
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
90
Eerstegraads connecties
3
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 3 |
|---|---|
Anderson University
 Anderson University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of Texas at Austin
 The University of Texas at Austin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Alaunos Therapeutics, Inc.
 Alaunos Therapeutics, Inc. BiotechnologyHealth Technology Develops a portfolio of immuno-oncology therapies | Health Technology |
